IMFINZI
Google image searchProduct monograph
Active ingredient
durvalumab, 50 MG/ML
DIN: 02468816
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription / Schedule D
Company: ASTRAZENECA CANADA INC
Date: 20-NOV-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
- L01FF — PD-1/PD-L1 (Programmed cell death protein 1/death ligand 1) inhibitors (ATC, ATC/DDD)
- L01FF03 — DURVALUMAB (ATC/DDD)
External Links for Imfinzi
Search on Google
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find imfinzi photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.